A phase II randomized, double-blind, multicenter, placebo-controlled, dose-ranging, parallel group study to compare the efficacy, safety and tolerability of three strengths of ad 452 in adult subjects with active rheumatoid arthritis

Sheitanov, Y; Povoroznyuk, V; Dimic, Aleksandar N; Bookbinder, S; George, M; Gauler, G; von, Hinuber U; Walker, D; Braun, Juergen; Fear, S; Fritchley, S; Tansley, R; Baker, H

Results

eNauka > Results > A phase II randomized, double-blind, multicenter, placebo-controlled, dose-ranging, parallel group study to compare the efficacy, safety and tolerability of three strengths of ad 452 in adult subjects with active rheumatoid arthritis

Title:	A phase II randomized, double-blind, multicenter, placebo-controlled, dose-ranging, parallel group study to compare the efficacy, safety and tolerability of three strengths of ad 452 in adult subjects with active rheumatoid arthritis
Authors:	Sheitanov, Y; Povoroznyuk, V; Dimic, Aleksandar N; Bookbinder, S; George, M; Gauler, G; von, Hinuber U; Walker, D; Braun, Juergen; Fear, S; Fritchley, S; Tansley, R; Baker, H;
Issue Date:	2007
Publication:	ANNALS OF THE RHEUMATIC DISEASES
ISSN:	0003-4967 Annals of the Rheumatic Diseases Search Idenfier
Type:	Conference Paper
Collation:	vol. 66 str. 448-448
WoS-ID:	000253101101717
URI:	https://enauka.gov.rs/handle/123456789/796589
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	Mp. category will be shown later

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM